Short-term bone loss in HIV-infected premenopausal women - Wikidata - awgldk - TriplyDB

Short-term bone loss in HIV-infected premenopausal women

Short-term bone loss in HIV-infected premenopausal women

http://www.wikidata.org/entity/Q33618567

about

Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study.Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study.Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study.Racial differences in bone loss and relation to menopause among HIV-infected and uninfected women.Bone disease in HIV infection.Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study.Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York.Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study.Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.Fractures after antiretroviral initiation.Trabecular and cortical microarchitecture in postmenopausal HIV-infected women.Vitamin D in HIV-Infected Patients.DUAL-ENERGY X-RAY ABSORPTIOMETRY AND CALCULATED FRAX RISK SCORES MAY UNDERESTIMATE OSTEOPOROTIC FRACTURE RISK IN VITAMIN D-DEFICIENT VETERANS WITH HIV INFECTION.The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations.Bone Disease in HIV: Recommendations for Screening and Management in the Older Patient.A Direct Comparison of the Effects of the Antiretroviral Drugs Stavudine, Tenofovir and the Combination Lopinavir/Ritonavir on Bone Metabolism in a Rat Model.Physiological and pathophysiological bone turnover - role of the immune system.Bone Loss Among Women Living With HIV.Associations of Low Vitamin D and Elevated Parathyroid Hormone Concentrations With Bone Mineral Density in Perinatally HIV-Infected Children.Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.

P2860

Q28728374-3855730D-9372-43D9-A317-6A9F9594E430 Q33627227-35863C07-AECE-4FA5-AF84-5C583086EF09 Q34116648-44D361F7-EA55-48C6-9F1B-D9E91290D2ED Q34355660-65362834-3FA4-484A-B907-CE7C15766719 Q35024409-B96FD000-AC7E-4B53-A61D-9EC9CC788A27 Q35291766-C1F55D80-7B57-4E72-A6F3-FC3DCE620379 Q35505203-7A0EACCA-0719-4D84-B85B-3AC239A85D0E Q35564782-5064E1AD-333F-4240-BE8E-F98A4256E2CD Q35593296-640DDA51-A2A0-4BD6-89F5-9423DB1DCFA5 Q35744467-F8376BEE-71E6-42BD-A990-E5FB13B9D80A Q36019580-789A9660-4CBB-4CDA-B19A-668498E07BB6 Q36087907-A8178F0E-B729-44E1-A8D1-7E9E6C23289E Q36177899-82F84AFC-9418-4E72-94D6-1A1E9B59D696 Q36389108-AC8A6C16-8810-44B2-A15E-F1BD498523D3 Q36462148-4789AD49-A6D6-468A-99E3-B8CF9002AFD7 Q36783435-16091F7C-D1E6-4034-8C7A-C0C2177333AA Q36839748-D233D8F7-CBA7-448F-B17E-CBE04C9598C2 Q36849920-2A20B237-3F08-4F12-96DA-2C2ADE2BEEF9 Q36884537-37664812-3CE2-4252-8D66-0591ECC67A8D Q37725096-99C1DCE3-F459-49D9-9462-D08EB94E1F6D Q37838799-6D447A02-C936-4164-B35B-40B37A5884F8 Q38540406-C8AA6902-0A7E-4D8B-BE8F-BE13C35787FE Q38772820-9FD5BF93-FDD5-4597-B847-B952BBA6089A Q38867785-0BF9B9AE-4292-4D3C-8F0B-D1C282BFEA2D Q38966358-E5362AEB-384C-4140-92BF-A67FE6522F16 Q40087344-E6A7BEA5-2FC5-46F9-A1A7-56D1EDD17911 Q40874258-1ACBD566-701C-461D-BADF-E10A085E86FB Q42281798-26537A3B-074F-4B7C-B67A-A5B66A2BF861 Q54211761-10D0CEE7-1C72-4356-B7A7-B0C98F76DEFA

P2860

Short-term bone loss in HIV-infected premenopausal women

http://www.wikidata.org/entity/Q33618567

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Short-term bone loss in HIV-infected premenopausal women

@ast

Short-term bone loss in HIV-infected premenopausal women

@en

type

label

Short-term bone loss in HIV-infected premenopausal women

@ast

Short-term bone loss in HIV-infected premenopausal women

@en

prefLabel

Short-term bone loss in HIV-infected premenopausal women

@ast

Short-term bone loss in HIV-infected premenopausal women

@en

P1433

Q33618567-F5C949BF-C16F-42E2-9A9E-146D94007656

P1476

Q33618567-C05C97BC-F30F-40CB-BD74-2FD983EA1956

P2093

Q33618567-11E34CF3-55D7-49A8-AF71-DFACCBA4ED44

Q33618567-171F920E-42EA-401D-8ADF-70DEB3920102

Q33618567-7B3038EB-3E43-421A-9602-B82F4B95782A

Q33618567-8060D66C-3BF0-49D9-8235-C01D0E74BDE2

Q33618567-8937C2F5-801B-4BA8-B02C-A656A1C81756

Q33618567-B9D7D47F-43ED-435D-AFAC-73D633AE0868

Q33618567-D08F5837-AC71-4CF8-9AF1-06AA21E5DEEC

Q33618567-E311E3D7-7E97-44D3-B25E-5CFD27242F06

Q33618567-EB48AF65-A66D-48FB-92DB-4A2E1A060225

P2860

Q33618567-00BEFD29-1F46-45AF-B191-F5D4DAF42DE0

Q33618567-05497499-D9E8-4C79-B716-CB8BF48A1924

Q33618567-0B0610EB-0870-4581-9310-310F709CAC34

Q33618567-0E15A453-95B9-4EE9-B755-E5119BD8AF0A

Q33618567-0FB699DC-9BA8-498E-AD94-927C6837901B

Q33618567-1E6937F7-C26A-4F11-8E54-879890A438AB

Q33618567-28BDA9C6-D59D-4E91-9214-830C358E9B61

Q33618567-2957F570-0BDD-4B47-A20D-EF876FF7F397

Q33618567-2CDBF62C-7189-428E-B158-DF8DD3C01EEF

Q33618567-3176A9E6-82F4-40CC-84A1-08CB31338E75

P304

Q33618567-0D6D7475-3ED0-4ADF-9582-A439FF5437B6

P31

Q33618567-8CAD58D3-6EBA-4B49-84FF-D4EDE48613FD

P356

Q33618567-992243F7-8F2B-45F2-8A18-140FFED74047

P407

Q33618567-54C13886-DC5B-4A29-9DA8-C1FF08816249

P433

Q33618567-D7C4982D-F962-46BE-A9B4-ED5430CE1D51

P478

Q33618567-5942CA3D-D26F-4433-B99A-5D8C3B362B85

P577

Q33618567-D7C9FE02-5590-4294-8E4C-7048CD2B238C

P698

Q33618567-8E641324-7950-40F8-8D3F-DCFDDD40FF71

P932

Q33618567-5EB929F6-2B3B-4600-B5E6-545416E3FD1A

P356

QAI.0B013E3181BF6471

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Short-term bone loss in HIV-infected premenopausal women

@en

P2093

Dalian Lu

http://www.w3.org/2001/XMLSchema#string

Elizabeth Shane

http://www.w3.org/2001/XMLSchema#string

Elizabeth T Golub

http://www.w3.org/2001/XMLSchema#string

Kathryn Anastos

http://www.w3.org/2001/XMLSchema#string

Mardge H Cohen

http://www.w3.org/2001/XMLSchema#string

Michael T Yin

http://www.w3.org/2001/XMLSchema#string

Phyllis C Tien

http://www.w3.org/2001/XMLSchema#string

Qiuhu Shi

http://www.w3.org/2001/XMLSchema#string

Serge Cremers

http://www.w3.org/2001/XMLSchema#string

P2860

Host factors and the pathogenesis of HIV-induced disease.

Diagnosis of osteoporosis and assessment of fracture risk.

Bone mass and mineral metabolism in HIV+ postmenopausal women.

Longitudinal analysis of bone density in human immunodeficiency virus-infected women

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.

Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.

CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis.

Do we still need a cohort study of women with HIV infection?

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.

HIV infection and bone mineral density in middle-aged women.

P304

202-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E3181BF6471

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19890216

http://www.w3.org/2001/XMLSchema#string

P932

2813405

http://www.w3.org/2001/XMLSchema#string